[{"indications": "Indications\u00a0suppression of inflammatory and allergic\r\ndisorders; severe inflammatory bowel disease (section 1.5); cerebral oedema associated with\r\nmalignancy; see also notes above; rheumatic disease (section 10.1.2); skin (section 13.4)", "name": "METHYLPREDNISOLONE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.3 Corticosteroids", "6.3.2 Glucocorticoid therapy"], "cautions": "Cautions\u00a0\n(From Cautions and contra-indications of corticosteroids: British National Formulary)\nCautions and contra-indications of corticosteroids; also rapid intravenous administration of large doses associated with cardiovascular\r\ncollapse", "side-effects": "Side-effects\u00a0\n(From Side-effects of corticosteroids: British National Formulary)\nSide-effects of corticosteroids", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4284.htm", "doses": ["By mouth, usual range 2\u201340\u00a0mg daily; see\r\nalso Administration (above)", "By intramuscular injection or slow intravenous injection or infusion, initially 10\u2013500\u00a0mg; graft rejection, up to 1\u00a0g\r\ndaily by intravenous infusion for up to 3 days"], "pregnancy": "Pregnancy\u00a0\n(From Pregnancy and breast-feeding: British National Formulary)\nPregnancy and breast-feeding"}, {"indications": "Indications\u00a0suppression of inflammatory and allergic\r\ndisorders; severe inflammatory bowel disease (section 1.5); cerebral oedema associated with\r\nmalignancy; see also notes above; rheumatic disease (section 10.1.2); skin (section 13.4)", "name": "METHYLPREDNISOLONE Intramuscular depot", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.3 Corticosteroids", "6.3.2 Glucocorticoid therapy", "METHYLPREDNISOLONE", "Intramuscular depot"], "cautions": "Cautions\u00a0\n(From Cautions and contra-indications of corticosteroids: British National Formulary)\nCautions and contra-indications of corticosteroids; also rapid intravenous administration of large doses associated with cardiovascular\r\ncollapse", "side-effects": "Side-effects\u00a0\n(From Side-effects of corticosteroids: British National Formulary)\nSide-effects of corticosteroids", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4290.htm", "doses": ["By mouth, usual range 2\u201340\u00a0mg daily; see\r\nalso Administration (above)", "By intramuscular injection or slow intravenous injection or infusion, initially 10\u2013500\u00a0mg; graft rejection, up to 1\u00a0g\r\ndaily by intravenous infusion for up to 3 days", "Name[Depo-Medrone\u00ae (Pharmacia) ] Injection (aqueous suspension), methylprednisolone  acetate 40\u00a0mg/mL. Net price 1-mL vial\r\n= \u00a32.87; 2-mL vial = \u00a35.15; 3-mL vial = \u00a37.47. \r\n    Label:\r\n    10, steroid cardDose\u00a0by deep intramuscular injection into gluteal\r\nmuscle, 40\u2013120\u00a0mg, a second injection may be given after 2\u20133 weeks\r\nif required"], "pregnancy": "Pregnancy\u00a0\n(From Pregnancy and breast-feeding: British National Formulary)\nPregnancy and breast-feeding"}]